Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart
  • Log out

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions

Novel magnetic resonance technique for functional imaging of cystic fibrosis lung disease

Sylvia Nyilas, Grzegorz Bauman, Gregor Sommer, Enno Stranzinger, Orso Pusterla, Urs Frey, Insa Korten, Florian Singer, Carmen Casaulta, Oliver Bieri, Philipp Latzin
European Respiratory Journal 2017 50: 1701464; DOI: 10.1183/13993003.01464-2017
Sylvia Nyilas
1Pediatric Respiratory Medicine, Dept of Pediatrics, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
9Contributed equally as first authors
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Grzegorz Bauman
2Dept of Radiology, Division of Radiological Physics, University of Basel Hospital, Basel, Switzerland
3Dept of Biomedical Engineering, University of Basel, Basel, Switzerland
9Contributed equally as first authors
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gregor Sommer
4Clinic of Radiology and Nuclear Medicine, University of Basel Hospital, Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Gregor Sommer
Enno Stranzinger
5Dept of Interventional and Pediatric Radiology, Inselspital, Bern University Hospital, Bern, Switzerland
6Division of Radiological Physics,Clinic of Radiology and Nuclear Medicine, University of Bern Hospital, Bern, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Orso Pusterla
2Dept of Radiology, Division of Radiological Physics, University of Basel Hospital, Basel, Switzerland
3Dept of Biomedical Engineering, University of Basel, Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Urs Frey
7University Children's Hospital Basel (UKBB), Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Insa Korten
1Pediatric Respiratory Medicine, Dept of Pediatrics, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Florian Singer
1Pediatric Respiratory Medicine, Dept of Pediatrics, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
8Division of Respiratory Medicine, University Children's Hospital Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Florian Singer
Carmen Casaulta
1Pediatric Respiratory Medicine, Dept of Pediatrics, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Oliver Bieri
2Dept of Radiology, Division of Radiological Physics, University of Basel Hospital, Basel, Switzerland
3Dept of Biomedical Engineering, University of Basel, Basel, Switzerland
10Contributed equally as senior authors
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philipp Latzin
1Pediatric Respiratory Medicine, Dept of Pediatrics, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
10Contributed equally as senior authors
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: philipp.latzin@insel.ch
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Lung function tests are commonly used to monitor lung disease in cystic fibrosis (CF). While practical, they cannot locate the exact origin of functional impairment. Contemporary magnetic resonance imaging (MRI) techniques provide information on the location of disease but the need for contrast agents constrains their repeated application. We examined the correlation between functional MRI, performed without administration of contrast agent, and lung clearance index (LCI) from nitrogen multiple-breath washout (N2-MBW).

40 children with CF (median (range) age 12.0 (6–18) years) and 12 healthy age-matched controls underwent functional and structural MRI and lung function tests on the same day. Functional MRI provided semiquantitative measures of perfusion (RQ) and ventilation (RFV) impairment as percentages of affected lung volume. Morphological MRI was evaluated using CF-specific scores. LCI measured global ventilation inhomogeneity.

MRI detected functional impairment in CF: RFV 19–38% and RQ 16–35%. RFV and RQ correlated strongly with LCI (r=0.76, p<0.0001 and r=0.85, p<0.0001, respectively), as did total morphology score (r=0.81, p<0.0001). All indices differed significantly between patients with CF and healthy controls (p<0.001).

Noninvasive functional MRI is a promising method to detect and visualise perfusion and ventilation impairment in CF without the need for contrast agents.

Abstract

New functional MRI without the need for contrast agents correlates strongly with ventilation inhomogeneity in CF http://ow.ly/emo930eQJ67

Introduction

Chronic lung diseases are highly prevalent in both children and adults. One of the most severe chronic lung diseases in childhood is cystic fibrosis (CF). CF is the most common autosomal recessive genetic disease in Caucasians [1]. Early diagnosis by newborn screening and improvement of therapy has raised interest in diagnostic tools to detect lung function impairment early and prior to irreversible lung damage [2–4]. Current techniques such as nitrogen multiple-breath washout (N2-MBW) or high-resolution computer tomography (HRCT) allow monitoring of early lung disease [5, 6]. However, both techniques are constrained by methodological drawbacks. N2-MBW estimates global ventilation inhomogeneity by the lung clearance index (LCI), but does not provide the exact location of underlying changes and more specific indices for ventilation inhomogeneities are not yet widely used [7, 8]. The cumulative radiation exposure of HRCT is low [9–11], but problematic for routine follow-up, and breathing manoeuvres are demanding for younger children.

In this regard, magnetic resonance imaging (MRI) is a rapidly evolving, radiation-free imaging technique to investigate the morphology and function of the lungs [12, 13]. Nonproton MRI techniques with inhaled hyperpolarised gaseous tracers such as 3He and 129Xe have been shown to provide the best static and dynamic ventilation image quality [14–16]. Nevertheless, the clinical application of these techniques is impeded by limited availability and the high costs of gases, hardware and trained personnel. Alternatively, pulmonary ventilation can also be assessed by proton MRI using T1-shortening oxygen as a gaseous tracer [17]. A recent study using promising contrast enhancement MRI [18, 19] showed a close correlation between lung function and MRI outcomes [20]. A drawback of this method is the need for a contrast agent and possible adverse effects, e.g. painful procedures, allergic reactions or neuronal tissue deposition of contrast media [21, 22].

To overcome those drawbacks, a new MRI technique, termed matrix pencil (MP) decomposition, a derivative of the Fourier decomposition (FD) method, was developed for evaluation of regional fractional ventilation and relative perfusion of the lung [23]. This novel MRI technique provides visual and numeric information of functional deficits in perfusion and ventilation domains of the lung. Importantly, intravenous contrast, inhaled tracers or breath-holding manoeuvres are not required; the technique is applicable during free tidal breathing.

The aim of this study was to assess whether indices from functional MRI differ between healthy controls and patients with CF. We further analysed the correlation between this new functional MRI method and N2-MBW in children with CF. We hypothesised that functional MRI detects fractional ventilation and relative perfusion defects in CF lung disease and that these indices relate to lung function.

Methods

Study design

This was a prospective, cross-sectional, single-centre, observational study at the University Children's Hospital of Bern, Bern, Switzerland, conducted between February 2016 and May 2017. Participants underwent N2-MBW, spirometry, body plethysmography and MRI on the same day, in that order.

Study population

We enrolled 40 unselected children with CF (supplementary table E1) across a wide age range (6–18 years), irrespective of bacterial colonisation or antibiotic use, to ensure a broad range of disease severity. Eligibility criteria were a confirmed diagnosis of CF, the ability to perform pulmonary function tests and MRI, and not requiring supplemental oxygen therapy. Healthy age-matched controls had neither a history of chronic lung disease nor acute respiratory infection in the 4 weeks prior to the investigations. The study was approved by the Ethics Committee of Bern (EKNZ 2015-326 and KEK 2017-00279). We obtained written informed consent from parents and participants, if older than 14 years.

MRI data acquisition and evaluation

Examinations were performed on a 1.5 T whole-body MRI scanner (MAGNETOM Aera; Siemens Healthineers, Erlangen, Germany) using a 12-channel thorax and a 24-channel spine receiver coil array. Sedation was not applied. Parents or caregivers were allowed to accompany children in the scanner cabin during imaging. Functional MRI scans were followed by morphological MRI scans. Regional fractional lung ventilation and relative perfusion were assessed using MP-MRI to acquire multiple coronal slices to cover the whole lung volume with a time-resolved ultra-fast steady-state free precession pulse sequence [24]. Details of scan parameters are given in supplementary table E2. Voxel distributions were used to estimate functional impairment. A similar thresholding method was used previously in a study comparing FD-MRI with dynamic contrast-enhanced MRI in CF patients [25]. For sensitivity analysis we additionally used 60% deviation as cut-off. The primary outcomes were percentage of the lung volume with impaired fractional ventilation RFV and relative perfusion RQ (supplementary figure E1), and morphological assessment based on a protocol previously described by Eichinger et al. [26] for MRI in CF (supplementary table E3). Secondary outcomes were diagnostic quality, measurement duration (supplementary material) and interobserver agreement between the two readers.

Lung function testing

N2-MBW was performed with an unmodified device (Exhalyzer D; Eco Medics, Duernten, Switzerland) according to consensus [27]. Primary outcome was the LCI, calculated as cumulative expired volume over functional residual capacity, for global ventilation inhomogeneity. Secondary outcomes were phase III slope indices Scond and Sacin for convection- and diffusion convection-dependent ventilation inhomogeneity, respectively [27].

Spirometry and body plethysmography (Jaeger MasterScreen; CareFusion, Hochberg, Germany) were performed after N2-MBW, according to European Respiratory Society/American Thoracic Society guidelines [28]. Outcomes were forced expiratory volume in 1 s (FEV1) and forced vital capacity from spirometry, and the ratio of residual volume and total lung capacity (RV/TLC).

Statistical analysis

We first assessed differences in MRI and lung function indices between patients with CF and healthy controls. In a second step we examined a possible correlation between functional indices from MRI and lung function. In a third step we examined the correlation between the morphological pathologies and lung function. For this, we used the mean of the morphological scores from both readers. Upper limit of normal was calculated using the mean+1.64sd of equipment-specific reference values for N2-MBW [29] and data from healthy age-matched controls for functional MRI indices. Continuous variables were compared with the Wilcoxon–Mann–Whitney test, as appropriate. All correlations were described with Spearman's rank correlation coefficient (r). Interobserver agreement was calculated using the intraclass correlation coefficient (ICC). In general, ICC was defined as very good (>0.80), good (0.6–0.80) or moderate (0.4–0.59) [30]. p-values <0.05 were considered statistically significant. As appropriate, Bonferroni correction was used for multiple comparisons. Analyses were performed using Stata version 13 (StataCorp, College Station, TX, USA) and Matlab version 2012b (MathWorks, Natick, MA, USA). Additional details and the sample size calculation are provided in the supplementary material.

Results

Participants

MRI scans, N2-MBW, spirometry and body plethysmography were successfully performed in all 40 patients with CF (median (range) age 12.0 (6–18) years) and all 12 healthy controls (median (range) age 12.0 (5–17) years). Characteristics of study participants are presented in supplementary table E1.

Data quality and measurement duration

Fractional ventilation and relative perfusion images were feasible and generated for all datasets obtained. In patients with CF, the mean (range) duration of the functional MRI scans was 5.6 (4.4–8.1) min and of the morphological MRI scans was 18.2 (13.2–24.6) min (supplementary table E4). Values were similar in healthy controls (supplementary table E5). Functional and morphological images from one healthy participant, one patient with a mild course of CF and one patient with a severe course of CF (based on FEV1 values) are shown in figures 1, 2 and 3, respectively.

Comparison between healthy controls and patients with CF

Fractional ventilation impairment from functional MRI differed significantly between healthy controls and patients with CF (median (IQR) 17.1 (14.6–20.6) versus 29.4 (24.9–31.9); p<0.001) (supplementary figure E2). Likewise relative perfusion impairment differed significantly between both groups (median (IQR) 15.1 (13.4–17.4) versus 27.1 (22.9–29.2); p<0.001) (supplementary figure E3). Morphological MRI score revealed minimal structural changes in only four healthy controls (for both readers total score ranged from 0 to 3), while showing a wide range of structural changes in patients with CF (supplementary table E4). Indices from N2-MBW differed significantly between groups, as to a lesser degree did some outcomes from spirometry and body plethysmography (supplementary table E6).

Interestingly, two patients with CF had results within the normal range in all functional modalities, two patients with CF showed compromised relative perfusion and fractional ventilation while LCI was within normal limits, and 17 patients with CF had normal FEV1 results, but compromised fractional ventilation and relative perfusion assessed by functional MRI (figures 4a and b, and supplementary figures E4 and E5).

FIGURE 1
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 1

Example of a healthy child: a 7-year-old healthy boy. a) Coronal and b) axial 5-mm T2-weighted BLADE and HASTE (half-Fourier acquisition single-shot turbo spin-echo) images, respectively. Chest magnetic resonance imaging (MRI) was normal. c, d) Functional MRI shows fairly homogeneous distribution of c) fractional ventilation as well as d) relative perfusion. Small regions in both lungs were classified as hypoperfused as well as peripheral regions in the middle lobe of the right lung as hypoventilated. e, f) Masks overlaid on morphological images present e) fractional ventilation defects (5% of the slice area) and f) perfusion defects (4% of the slice area). Both lung clearance index (5.7 lung turnovers) and forced expiratory volume in 1 s (−0.30 z-scores) were normal.

FIGURE 2
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 2

Example of a child with mild lung disease: a 9-year-old boy with cystic fibrosis. a) Coronal and b) axial 5-mm T2-weighted HASTE (half-Fourier acquisition single-shot turbo spin-echo) sequences. Mild bronchial wall thickening (b, arrows) is noted in the right lower lobe (Eichinger Score 1 (R1)). Otherwise normal chest magnetic resonance imaging (MRI). c) Functional MRI shows two main areas with reduced fractional ventilation located in the upper lobe of the right lung and basal part of the left lung. d) Relative perfusion map shows several regions with reduced perfusion in both lungs. e, f) Masks overlaid on morphological images present e) fractional ventilation defects (16% of the slice area) and f) perfusion defects (19% of the slice area). Lung clearance index was at the upper limit of normal (8.4 lung turnovers) and forced expiratory volume in 1 s was normal (0.46 z-scores).

FIGURE 3
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 3

Example of a child with advanced lung disease: a 12-year-old girl with cystic fibrosis. a) Coronal HASTE (half-Fourier acquisition single-shot turbo spin-echo) sequence shows mild bronchiectasis and peribronchial infiltrates in the right upper lobe (arrow) (Eichinger Score 10 (R1)). b) Axial T2-weighted BLADE sequence shows moderate bronchial wall thickening in the right upper lobe (short arrow) and mucus plugging in the right upper lobe (long arrow). c, d) Functional magnetic resonance imaging shows c) large regions with reduced fractional ventilation, which are spatially matched with d) areas of decreased relative perfusion. e, f) Masks overlaid on morphological images present e) fractional ventilation defects (36% of the slice area) and f) relative perfusion defects (31% of the slice area). Both lung clearance index (13.4 lung turnovers) and forced expiratory volume in 1 s (−3.1 z-scores) showed pathological values.

FIGURE 4
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 4

Correlation between lung clearance index (LCI) and impairment of the lung for patients with cystic fibrosis (CF) and healthy age-matched controls: a) fractional ventilation (RFV) and b) relative perfusion (RQ). Upper limit of normal is given as dashed lines for both modalities: LCI 8.0 lung turnovers, RFV 24.2% and RQ 19.3%.

Correlation between functional MRI and lung function in patients with CF

In patients with CF, the extent of impaired ventilation relative to lung volume (RFV) quantified by functional MRI was between 19% and 38% (supplementary table E4). We found a strong correlation between RFV and LCI (r=0.76, p<0.0001), as well as a correlation between RFV, Scond and Sacin (table 1 and figure 4a). We found a strong correlation between RFV and FEV1 (r= −0.64, p<0.0001) (supplementary figure E4). The RV/TLC ratio correlated with indices of functional MRI (table 1).

View this table:
  • View inline
  • View popup
TABLE 1

Functional magnetic resonance imaging (MRI) versus lung function outcomes in the 40 patients with cystic fibrosis

The extent of impaired perfusion relative to lung volume (RQ) was between 16% and 35% (supplementary table E4). RQ showed a significant, excellent correlation with LCI (r=0.85, p<0.0001) (table 1 and figure 4b). Scond also correlated with RQ (r=0.62, p<0.0001) in comparison with a correlation between Sacin and RQ (r=0.44, p=0.0049). We found a correlation between FEV1 and RQ (r= −0.67, p<0.0001) (supplementary figure E5). Changes in threshold by using 60% of the median value of the voxel distribution did not change the correlation between LCI, RFV and RQ (r=0.77, p<0.0001 and r=0.8, p<0.0001, respectively).

Correlation between morphological MRI score and lung function

The total morphology score in patients with CF ranged from 0 to 31 for both readers. For detailed subscores, see supplementary table E4. We found excellent correlation between LCI and total morphology scores (r=0.81, p<0.0001), as well as the subscores for bronchiectasis and bronchial wall thickening (r=0.81, p<0.0001) and mucus plugging (r=0.79, p<0.0001). We also found a correlation between the total morphology scores and Scond (r=0.70, p<0.0001), as well as subscores. FEV1 correlated with the total morphology score (r= −0.66, p<0.0001) (table 2).

View this table:
  • View inline
  • View popup
TABLE 2

Correlation between lung function parameters with magnetic resonance imaging (MRI)-defined morphological pathologies in lung structure in the 40 patients with cystic fibrosis

Inter-reader correlation in patients with CF

Correlation between both readers was strong for total morphology score (r=0.84, p<0.0001), bronchiectasis/air wall thickening (r=0.73, p<0.0001) and mucus plugging (r=0.85, p<0.0001) (supplementary table E4). Calculation of the correlation between the scores of each reader separately and lung function values resulted in similar findings for reader1 and reader2, e.g. total morphology score and LCI (r=0.77 for reader1 and r=0.77 for reader2; p<0.0001). Agreement (ICC) between readers was good, with 0.64 for total morphology score and 0.63 for airway wall thickening and bronchiectasis (supplementary table E4).

Discussion

Main findings

Functional MRI reliably detected ventilation and perfusion defects in children at various stages of CF lung disease. The findings differed significantly compared with the group of healthy controls. This is the first study to examine a function–function correlation between two modalities using the combination of a novel proton-based functional MP-MRI technique and N2-MBW in patients with CF and healthy controls. The extent of ventilation and perfusion impairment detected by functional MRI is physiologically plausible as the correlation with LCI is strong. The main technical advantage of the new MRI technique is the contrast-agent-free application during normal tidal breathing. Structure–function correlation was also strong between an established morphological CF score and LCI [20]. Furthermore, we revealed a good agreement between both readers for morphological MRI scores. The short duration required to obtain functional MRI is especially attractive for application in children, and when considering time constraints in radiology departments and outpatient clinics. This novel MRI technique appears applicable to most lung diseases that are not primarily characterised by interstitial remodelling.

Comparison with previous studies

Technical considerations

Lung imaging for clinical routine or clinical trial outcome assessment should be sensitive, fast, safe, noninvasive and easily applicable even in children, as structural and functional airway pathologies already occur in asymptomatic infants and children with CF [1, 4, 13]. In this study, we performed measurements with a non-contrast-enhanced functional MRI using MP decomposition. This technique has been validated against different modalities, e.g. CT, dynamic contrast enhancement MRI and hyperpolarised noble gas MRI, in human and animal models [25, 31–33]. These studies determined a good correlation with dynamic contrast enhancement and hyperpolarised noble gas MRI, and a high test reproducibility. Furthermore, a good reproducibility of the applied functional MRI method in healthy volunteers was shown [34]. Recently, a study using a FD-based self-gated non-contrast-enhanced functional lung imaging technique called SENCEFUL in patients with CF was reported by Veldhoen et al. [35]. Results are not directly comparable, as Veldhoen et al. [35] also studied adult patients with more severe lung disease and they only assessed impairment of ventilation. Still, they also report a significant difference in ventilation efficiency between patients and controls. Furthermore, despite the slightly more severe course of disease in their population and the different MRI techniques, associations between impairment of ventilation and FEV1 are surprisingly comparable between studies (r=0.65 and 0.64, respectively). Of note, MP-MRI as used in our study does not measure the information on regional ventilation and perfusion directly, but by the extraction of signal modulations in the lung caused by the change of lung parenchyma density and regional blood flow.

Physiological considerations

Interestingly, we found that lung function changes measured at the mouth based on ventilation distribution efficiency of the whole lung are well associated with impairment in ventilation and perfusion detected by local imaging of the lung. Our data thereby confirm the concept of LCI being a sensitive marker of global ventilation distribution.

To capture the large range of variety in functional disease in CF phenotypes, which may even fluctuate over time, it is of great importance to use multimodal diagnostic technologies [36]. Functional MRI may detect clinically silent pathological processes earlier than even the already very sensitive N2-MBW. Before morphological changes occur, ventilation/perfusion in the lung is likely to be affected, but may be missed by previous imaging or lung function techniques. The quantification of ventilation/perfusion allows estimating early changes of the latter. This is particularly true with regard to the Euler–Liljestrand reflex, inducing vasoconstriction in unventilated peripheral lung compartments [37]. We chose LCI as the “gold standard” comparator for functional MRI indices because of its high repeatability, specificity and sensitivity to detect global ventilation inhomogeneity, a proxy for both central and peripheral airway involvement in CF [38]. However, global ventilation inhomogeneity is only detected if lung compartments are at least slowly ventilated. Scond, a parameter for convection-dependent ventilation inhomogeneity, strongly correlated with perfusion impairment, bronchiectasis and mucus plugging in the lung, and was moderately correlated with fractional ventilation impairment. A previous study already showed the high prevalence of elevated Scond values in CF, but did not find a correlation between lung function outcomes. This was explained by the theory that in the presence of a complete obliteration of small airways, Scond will not contribute to convective ventilation [39]. Whether these findings are epiphenomena or a reflection of a true structure–function interaction in small airways needs to be determined in longitudinal studies.

Strengths and limitations

Our findings are strengthened by the rigorously performed study design. We always adhered to the full protocol within a clinical setting and on the same day. The order was thus respected (i.e. first functional then morphological sequences). All data were obtained using standard commercially available equipment provided by the manufacturer. Morphological scores are reliable as agreement between both readers was good. However, short- and long-term repeatability require further study. Interestingly, function–function associations using two different but very sensitive techniques seem quite linear over a wide range of disease severity. This cannot be extrapolated to end-stage lung disease and very likely different outcome measures are more suitable in more severe disease.

The functional and morphological MRI protocols required up to 30 min compared with a HRCT scan examination which takes only 5 s. HRCT is currently the “gold standard” for imaging morphological changes of lung disease. Nevertheless, HRCT only provides detailed information on morphological impairment, whereas estimating trapped gas requires repeated scans and breathing manoeuvres. The free tidal breathing in our protocol could have influenced the estimation of the amount of air trapping in the patients [40]. Our study overcomes some risks from previous imaging modalities in CF, e.g. allergic sensitisation or anaphylactic reactions to contrast agents, deposition of contrast agents in tissue and cumulative ionising radiation dose, which is especially important as survival is steadily increasing in patients with CF [9, 21, 22].

Clinical relevance

With this study we emphasise the applicability of functional lung MRI in paediatric patients with CF. All MRI measurements were feasible and of good quality. The non-contrast-enhanced protocol, the free tidal breathing during the measurement, the nonionising radiation and the short time to perform functional MRI demonstrate the great advantages compared with commonly used imaging protocols and techniques. The “new era” of less severe disease, heralded by new treatment targets and better therapeutic options, demands sensitive physiological and structural outcomes to prevent irreversible airway changes. Personalised diagnostic tools enable personalised treatment, which currently plays an increasing role in clinical practice. Potentially reversible functional impairment can now be detected before irreversible morphological changes occur in the lungs. We want to draw attention to new functional imaging modalities and their combination with sensitive lung function indices to determine fractional ventilation impairment in the lung. The potential role of this MRI technique for other lung diseases, such as primary ciliary dyskinesia, chronic obstructive pulmonary disease or asthma, has to be investigated in future studies.

Conclusions

Functional MRI of the lung is feasible in children over 5 years of age and a promising diagnostic technique. Fractional ventilation and relative perfusion impairment of the lung correlate strongly with the LCI in patients with CF. Functional MRI has the potential to detect fractional ventilation and relative perfusion inhomogeneities, which may be the earliest changes of the airways and potentially still reversible. While confirmation in larger cohorts seems to be required, our results may promote the application of MRI as a quantitative morphological and functional test in chronic lung diseases such as CF.

Supplementary material

Supplementary Material

Please note: supplementary material is not edited by the Editorial Office, and is uploaded as it has been supplied by the author.

Supplementary material ERJ-01464-2017_Supplement

Figure E1. Data acquisition scheme. (A) Data acquisition scheme based on time-resolved imaging of multiple coronal slices (S1-S6) covering the chest volume. (B) Analysis of the voxel distribution extracted from segmented fractional ventilation and perfusion maps (on the left side), which were generated from the acquired MR data using the matrix pencil decomposition method. A threshold value equal to 0.75 of the median of the signal intensity distribution is calculated for every functional map separately. Lung regions with voxel values below the calculated threshold are regarded as areas of functional impairment and are visualized as a mask overlaid on the morphological image. Representative masks of fractional ventilation and perfusion defects are shown on the right side. ERJ-01464-2017_Figure_E1

Figure E2. Box plot of impairment of ventilation. Box plot of fractional impairment of ventilation from healthy controls (HC) and patients with cystic fibrosis (CF). ERJ-01464-2017_Figure_E2

Figure E3. Box plot of impairment of perfusion. Box plot of relative impairment of perfusion from healthy controls (HC) and patients with cystic fibrosis (CF). ERJ-01464-2017_Figure_E3

Figure E4. Correlation between FEV1 and fractional impairment of ventilation. Correlation between FEV1 and fractional impairment of ventilation (RFV) of the lung given in percentage. For illustration scale for FEV1 was reversed. Closed circles denote patients with CF and open circles illustrate healthy aged matched controls. For illustration we reversed the scale of FEV1. ULN is given in dashed lines for both modalities FEV1 (-1.64 z-scores), RFV (24.2%). ERJ-01464-2017_Figure_E4

Figure E5. Correlation between FEV1 and relative impairment of perfusion. Correlation between FEV1 and relative impairment of perfusion (RQ) of the lung given in percentage. For illustration scale for FEV1 was reversed. Closed circles denote patients with CF and open circles illustrate healthy aged matched controls. For illustration we reversed the scale of FEV1. ULN is given in dashed lines for both modalities FEV1 (-1.64 z-scores), RQ (19.3%). ERJ-01464-2017_Figure_E5

Disclosures

Supplementary Material

G. Bauman ERJ-01464-2017_Bauman

O. Bieri ERJ-01464-2017_Bieri

P. Latzin ERJ-01464-2017_Latzin

S. Nyilas ERJ-01464-2017_Nyilas

O. Pusterla ERJ-01464-2017_Pusterla

Acknowledgements

The authors would like to thank all of the children and their families for their participation in the study. The authors would also like to express their thanks especially to Sharon Schmidt, Linn Krueger, Tobias Ehrenreich, Sophie Yammine, Chiara Abbas (Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland); Bernd Jung, Michael Ith (Dept of Interventional and Pediatric Radiology, Inselspital, Bern University Hospital, Bern, Switzerland); Tanja Haas (Dept of Radiology, Division of Radiological Physics, University of Basel Hospital, Basel, Switzerland); and Philippe C. Cattin, Robin Sandkühler (Dept of Biomedical Engineering, University of Basel, Allschwil, Switzerland); and to all the study nurses and medical-technical assistants from the Dept of Radiology (Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland) for their patient care, support in measurements and recruitment of children.

Author contributions: S. Nyilas, G. Bauman, O. Pusterla, U. Frey, C. Casaulta, O. Bieri and P. Latzin designed the study concept. S. Nyilas collected study data. S. Nyilas, G. Bauman, G. Sommer and E. Stranzinger analysed the data. S. Nyilas, G. Bauman, G. Sommer, E. Stranzinger, O. Pusterla, U. Frey, I. Korten, F. Singer, C. Casaulta, O. Bieri and P. Latzin interpreted the data. S. Nyilas and G. Bauman drafted the manuscript. All authors revised the manuscript.

Footnotes

  • This article has supplementary material available from erj.ersjournals.com

  • Support statement: The work for this report was funded by the Swiss National Foundation (grant SNF 320030_149576), Swiss Cystic Fibrosis Foundation (CFCH) and Botnar Foundation. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. Funding information for this article has been deposited with the Crossref Funder Registry.

  • Conflict of interest: Disclosures can be found alongside this article at erj.ersjournals.com

  • Received January 13, 2017.
  • Accepted August 31, 2017.
  • Copyright ©ERS 2017

References

  1. ↵
    1. Grasemann H,
    2. Ratjen F
    . Early lung disease in cystic fibrosis. Lancet Respir Med 2013; 1: 148–157.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Davies J,
    2. Sheridan H,
    3. Bell N
    , et al. Assessment of clinical response to ivacaftor with lung clearance index in cystic fibrosis patients with a G551D-CFTR mutation and preserved spirometry: a randomised controlled trial. Lancet Respir Med 2013; 1: 630–638.
    OpenUrlCrossRefPubMed
    1. Ratjen F,
    2. Hug C,
    3. Marigowda G
    , et al. Efficacy and safety of lumacaftor and ivacaftor in patients aged 6–11 years with cystic fibrosis homozygous for F508del-CFTR: a randomised, placebo-controlled phase 3 trial. Lancet Respir Med 2017; 5: 557–567.
    OpenUrl
  3. ↵
    1. Tiddens HA
    . Detecting early structural lung damage in cystic fibrosis. Pediatr Pulmonol 2002; 34: 228–231.
    OpenUrlCrossRefPubMedWeb of Science
  4. ↵
    1. Ramsey KA,
    2. Rosenow T,
    3. Turkovic L
    , et al. Lung clearance index and structural lung disease on computed tomography in early cystic fibrosis. Am J Respir Crit Care Med 2016; 193: 60–67.
    OpenUrlPubMed
  5. ↵
    1. Singer F,
    2. Kieninger E,
    3. Abbas C
    , et al. Practicability of nitrogen multiple-breath washout measurements in a pediatric cystic fibrosis outpatient setting. Pediatr Pulmonol 2013; 48: 739–746.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Gustafsson PM,
    2. Robinson PD,
    3. Gilljam M
    , et al. Slow and fast lung compartments in cystic fibrosis measured by nitrogen multiple-breath washout. J Appl Physiol 2014; 117: 720–729.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Nyilas S,
    2. Schlegtendal A,
    3. Singer F
    , et al. Alternative inert gas washout outcomes in patients with primary ciliary dyskinesia. Eur Respir J 2017; 49: 1600466.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    1. Pearce MS,
    2. Salotti JA,
    3. Little MP
    , et al. Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study. Lancet 2012; 380: 499–505.
    OpenUrlCrossRefPubMedWeb of Science
    1. Kuo W,
    2. Ciet P,
    3. Tiddens HA
    , et al. Monitoring cystic fibrosis lung disease by computed tomography. Radiation risk in perspective. Am J Respir Crit Care Med 2014; 189: 1328–1336.
    OpenUrlCrossRefPubMed
  9. ↵
    1. O'Connor OJ,
    2. Vandeleur M,
    3. McGarrigle AM
    , et al. Development of low-dose protocols for thin-section CT assessment of cystic fibrosis in pediatric patients. Radiology 2010; 257: 820–829.
    OpenUrlCrossRefPubMedWeb of Science
  10. ↵
    1. Walkup LL,
    2. Thomen RP,
    3. Akinyi TG
    , et al. Feasibility, tolerability and safety of pediatric hyperpolarized 129Xe magnetic resonance imaging in healthy volunteers and children with cystic fibrosis. Pediatr Radiol 2016; 46: 1651–1662.
    OpenUrl
  11. ↵
    1. Wielpütz MO,
    2. Puderbach M,
    3. Kopp-Schneider A
    , et al. Magnetic resonance imaging detects changes in structure and perfusion, and response to therapy in early cystic fibrosis lung disease. Am J Respir Crit Care Med 2014; 189: 956–965.
    OpenUrlCrossRefPubMedWeb of Science
  12. ↵
    1. Fain S,
    2. Schiebler ML,
    3. McCormack DG
    , et al. Imaging of lung function using hyperpolarized helium-3 magnetic resonance imaging: review of current and emerging translational methods and applications. J Magn Reson Imaging 2010; 32: 1398–1408.
    OpenUrlCrossRefPubMed
    1. Mugler JP,
    2. Altes TA
    . Hyperpolarized 129Xe MRI of the human lung. J Magn Reson Imaging 2013; 37: 313–331.
    OpenUrlCrossRefPubMed
  13. ↵
    1. Smith L,
    2. Marshall H,
    3. Aldag I
    , et al. Longitudinal assessment of children with mild CF using hyperpolarised gas lung MRI and LCI. Am J Respir Crit Care Med 2017; in press [https://doi.org/10.1164/rccm.201705-0894LE].
  14. ↵
    1. Edelman RR,
    2. Hatabu H,
    3. Tadamura E
    , et al. Noninvasive assessment of regional ventilation in the human lung using oxygen-enhanced magnetic resonance imaging. Nat Med 1996; 2: 1236–1239.
    OpenUrlCrossRefPubMedWeb of Science
  15. ↵
    1. Wielpütz MO,
    2. Mall MA
    . MRI accelerating progress in functional assessment of cystic fibrosis lung disease. J Cyst Fibros 2017; 16: 165–167.
    OpenUrl
  16. ↵
    1. Wielpütz MO,
    2. Eichinger M,
    3. Biederer J
    , et al. Imaging of cystic fibrosis lung disease and clinical interpretation. Rofo 2016; 188: 834–845.
    OpenUrl
  17. ↵
    1. Stahl M,
    2. Wielputz MO,
    3. Graeber SY
    , et al. Comparison of lung clearance index and magnetic resonance imaging for assessment of lung disease in children with cystic fibrosis. Am J Respir Crit Care Med 2017; 195: 349–359.
    OpenUrl
  18. ↵
    1. Costello JR,
    2. Kalb B,
    3. Martin DR
    . Incidence and risk factors for gadolinium-based contrast agent immediate reactions. Top Magn Reson Imaging 2016; 25: 257–263.
    OpenUrl
  19. ↵
    1. McDonald RJ,
    2. McDonald JS,
    3. Kallmes DF
    , et al. Intracranial gadolinium deposition after contrast-enhanced MR imaging. Radiology 2015; 275: 772–782.
    OpenUrlCrossRefPubMed
  20. ↵
    1. Bauman G,
    2. Bieri O
    . Matrix pencil decomposition of time-resolved proton MRI for robust and improved assessment of pulmonary ventilation and perfusion. Magn Reson Med 2017; 77: 336–342.
    OpenUrl
  21. ↵
    1. Bieri O
    . Ultra-fast steady state free precession and its application to in vivo 1H morphological and functional lung imaging at 1.5 tesla. Magn Reson Med 2013; 70: 657–663.
    OpenUrl
  22. ↵
    1. Bauman G,
    2. Puderbach M,
    3. Heimann T
    , et al. Validation of Fourier decomposition MRI with dynamic contrast-enhanced MRI using visual and automated scoring of pulmonary perfusion in young cystic fibrosis patients. Eur J Radiol 2013; 82: 2371–2377.
    OpenUrlCrossRefPubMed
  23. ↵
    1. Eichinger M,
    2. Optazaite DE,
    3. Kopp-Schneider A
    , et al. Morphologic and functional scoring of cystic fibrosis lung disease using MRI. Eur J Radiol 2012; 81: 1321–1329.
    OpenUrlCrossRefPubMed
  24. ↵
    1. Robinson PD,
    2. Latzin P,
    3. Verbanck S
    , et al. Consensus statement for inert gas washout measurement using multiple- and single-breath tests. Eur Respir J 2013; 41: 507–522.
    OpenUrlAbstract/FREE Full Text
  25. ↵
    1. Miller MR,
    2. Hankinson J,
    3. Brusasco V
    , et al. Standardisation of spirometry. Eur Respir J 2005; 26: 319–338.
    OpenUrlAbstract/FREE Full Text
  26. ↵
    1. Anagnostopoulou P,
    2. Jensen R,
    3. Kranz N
    , et al. New reference values for N2 multiple breath washout outcomes in pre-school and school-aged children. Eur Respir J 2016; 48: PA371.
    OpenUrl
  27. ↵
    1. Portney L,
    2. Watkins M
    . Foundations of Clinical Research: Application to Practice. Stamford, Appleton & Lange, 1993.
  28. ↵
    1. Bauman G,
    2. Lützen U,
    3. Ullrich M
    , et al. Pulmonary functional imaging: qualitative comparison of Fourier decomposition MR imaging with SPECT/CT in porcine lung. Radiology 2011; 260: 551–559.
    OpenUrlCrossRefPubMedWeb of Science
    1. Bauman G,
    2. Puderbach M,
    3. Deimling M
    , et al. Non-contrast-enhanced perfusion and ventilation assessment of the human lung by means of Fourier decomposition in proton MRI. Magn Reson Med 2009; 62: 656–664.
    OpenUrlCrossRefPubMed
  29. ↵
    1. Bauman G,
    2. Scholz A,
    3. Rivoire J
    , et al. Lung ventilation- and perfusion-weighted Fourier decomposition magnetic resonance imaging: in vivo validation with hyperpolarized 3He and dynamic contrast-enhanced MRI. Magn Reson Med 2013; 69: 229–237.
    OpenUrl
  30. ↵
    1. Lederlin M,
    2. Bauman G,
    3. Eichinger M
    , et al. Functional MRI using Fourier decomposition of lung signal: reproducibility of ventilation- and perfusion-weighted imaging in healthy volunteers. Eur J Radiol 2013; 82: 1015–1022.
    OpenUrl
  31. ↵
    1. Veldhoen S,
    2. Weng AM,
    3. Knapp J
    , et al. Self-gated non-contrast-enhanced functional lung MR imaging for quantitative ventilation assessment in patients with cystic fibrosis. Radiology 2017; 283: 242–251.
    OpenUrl
  32. ↵
    1. Nyilas S,
    2. Singer F,
    3. Kumar N
    , et al. Physiological phenotyping of pediatric chronic obstructive airway diseases. J Appl Physiol 2016; 121: 324–332.
    OpenUrlAbstract/FREE Full Text
  33. ↵
    1. Paddenberg R,
    2. Mermer P,
    3. Goldenberg A
    , et al. Videomorphometric analysis of hypoxic pulmonary vasoconstriction of intra-pulmonary arteries using murine precision cut lung slices. J Vis Exp 2014; (83): e50970.
  34. ↵
    1. Aurora P,
    2. Stanojevic S,
    3. Wade A
    , et al. Lung clearance index at 4 years predicts subsequent lung function in children with cystic fibrosis. Am J Respir Crit Care Med 2011; 183: 752–758.
    OpenUrlCrossRefPubMedWeb of Science
  35. ↵
    1. Horsley AR,
    2. Macleod KA,
    3. Robson AG
    , et al. Effects of cystic fibrosis lung disease on gas mixing indices derived from alveolar slope analysis. Respir Physiol Neurobiol 2008; 162: 197–203.
    OpenUrlCrossRefPubMed
  36. ↵
    1. Bonnel AS,
    2. Song SMH,
    3. Kesavarju K
    , et al. Quantitative air-trapping analysis in children with mild cystic fibrosis lung disease. Pediatr Pulmonol 2004; 38: 396–405.
    OpenUrlCrossRefPubMedWeb of Science
PreviousNext
Back to top
View this article with LENS
Vol 50 Issue 6 Table of Contents
European Respiratory Journal: 50 (6)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Novel magnetic resonance technique for functional imaging of cystic fibrosis lung disease
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Novel magnetic resonance technique for functional imaging of cystic fibrosis lung disease
Sylvia Nyilas, Grzegorz Bauman, Gregor Sommer, Enno Stranzinger, Orso Pusterla, Urs Frey, Insa Korten, Florian Singer, Carmen Casaulta, Oliver Bieri, Philipp Latzin
European Respiratory Journal Dec 2017, 50 (6) 1701464; DOI: 10.1183/13993003.01464-2017

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Novel magnetic resonance technique for functional imaging of cystic fibrosis lung disease
Sylvia Nyilas, Grzegorz Bauman, Gregor Sommer, Enno Stranzinger, Orso Pusterla, Urs Frey, Insa Korten, Florian Singer, Carmen Casaulta, Oliver Bieri, Philipp Latzin
European Respiratory Journal Dec 2017, 50 (6) 1701464; DOI: 10.1183/13993003.01464-2017
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Abstract
    • Introduction
    • Methods
    • Results
    • Discussion
    • Supplementary material
    • Disclosures
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • CF and non-CF bronchiectasis
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Original Articles

  • Ambulatory management of secondary spontaneous pneumothorax
  • Systematic assessment of respiratory health in illness susceptible athletes
  • Identifying early PAH biomarkers in systemic sclerosis
Show more Original Articles

Cystic fibrosis

  • Novel mucolytic for treating muco-obstructive lung disease
  • The French compassionate programme of elexacaftor–tezacaftor–ivacaftor
  • Elexacaftor–tezacaftor–ivacaftor and monocyte microbicidal deficiency in CF
Show more Cystic fibrosis

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society